Ex-KuDOS team raise £6 million for new venture
This article was originally published in Scrip
Executive Summary
A management team originating from AstraZeneca buy-out KuDOS Pharmaceuticals has raised £6 million of venture financing to launch a new company. The investor syndicate was led by Sofinnova Partners, and included Imperial Innovations and two corporate venture investors, GlaxoSmithKline’s SR One and the Roche Venture Fund.